Cognitive Assessment for Stroke Patients: Reproductibility and Validity Study

Study Overview
=================
Brief Summary
-----------------
After a CVA, all of the cognitive functions can be affected and analysed, but the presence of a language disorder may considerably hamper the evaluation of other functions. The battery of rapid tests to screen for and quantify cognitive disorders, including the MMSE, the MOCA, the R-CAMCOG or the RBANS, are not suitable for aphasic patients because they contain items with a strictly verbal response. Because of this, inexperienced doctors cannot evaluate higher functions (other than language) of aphasics in routine practice. For the same reason, aphasics are regularly excluded from post-cva therapeutic protocols, whether or not the trial bears on the evolution of cognitive functions. Nonetheless, it is possible to evaluate, at least roughly, all of the cognitive functions without resorting to language. The investigator have developed , from validated tests and classical clinical manoeuvers, the Cognitive Assessment for Stroke Patients (CASP) : for the rapid screening (less than 15 minutes) and quantification of post-cva cognitive disorders (6 functions: language, apraxia, short-term memory, temporal orientation, impaired spatial/visio-construction and executive functions); the CASP can be used in most patients, including those with severe disorders of expression and moderate problems with comprehension, The format of these tests has been adapted so that severe disorders of expression (essentially left-hemisphere CVA), and left spatial impairment (right-hemisphere CVA) do not affect the ability to take the test. Its validity in terms of appearance and content were verified in 2011.

Conditions
-----------------
Stroke

Intervention / Treatment
-----------------
* Other: Cognitive Assessment test


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: For CVA patients patients hospitalised in rehabilitation after a first recent hemispheric CVA (less than 6 weeks) ; aged > 18; absence of severe disorders of oral comprehension (BDAE aphasia severity score >2 for comprehension); whatever the severity of oral expression disorders; who have been given clear written and oral information, and after the doctor has verified their ability to understand the protocol. For  Control  patients (to evaluate divergent validity) patients hospitalised in rehabilitation units or geriatrics taking part in this study; aged > 18. Exclusion Criteria: For CVA patients patients who do not speak French; cognitive disorders known before the CVA; psychotic disorders known before the CVA; major visual disorders incompatible with reading, known before the CVA. For  Control  patients (to evaluate divergent validity) patients who do not speak French; cognitive disorders known before the CVA; psychotic disorders known before the CVA; major visual disorders incompatible with reading, known before the CVA.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Other: Cognitive Assessment<br> | Other: Cognitive Assessment test<br> <br> |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| comprehensive assessment battery of higher functions |  | baseline | 
| comprehensive assessment battery of higher functions |  | Evaluation at 3 ±1 days | 
| comprehensive assessment battery of higher functions |  | Evaluation at 6 ± 2 weeks | 
| test of visual memory |  | baseline | 
| test of visual memory |  | Evaluation at 3 ±1 days | 
| test of visual memory |  | Evaluation at 6 ± 2 weeks |